PureTech Health (PRTC) News Today $20.28 -0.80 (-3.80%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period PureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading Volume - Time to Buy?PureTech Health (NASDAQ:PRTC) Sees Large Volume Increase - Time to Buy?December 19 at 12:57 PM | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down - Here's WhyPureTech Health (NASDAQ:PRTC) Shares Gap Down - Here's What HappenedDecember 17, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up - Should You Buy?PureTech Health (NASDAQ:PRTC) Shares Gap Up - Should You Buy?December 16, 2024 | marketbeat.comPureTech's Deupirfenidone Shows Positive Results In Slowing Lung Function Decline In IPF PatientsDecember 16, 2024 | markets.businessinsider.comPureTech's Deupirfenidone (LYT-100) Slowed Lung Function Decline in People with Idiopathic Pulmonary Fibrosis (IPF) as Measured by Forced Vital Capacity (FVC), Achieving the Primary and Key Secondary Endpoints in the ELEVATE IPF Phase 2b TrialDecember 16, 2024 | businesswire.comWith 71% institutional ownership, PureTech Health plc (LON:PRTC) is a favorite amongst the big gunsDecember 13, 2024 | finance.yahoo.comPureTech Health presents data from dose escalation phase of LYT-200 trialDecember 10, 2024 | markets.businessinsider.comPureTech Health (NASDAQ:PRTC) Shares Gap Up - What's Next?PureTech Health (NASDAQ:PRTC) Shares Gap Up - Here's WhyDecember 6, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Trading Down 3.8% - Here's What HappenedPureTech Health (NASDAQ:PRTC) Trading Down 3.8% - Time to Sell?November 29, 2024 | marketbeat.comLeerink Partnrs Comments on PureTech Health FY2024 EarningsPureTech Health plc (NASDAQ:PRTC - Free Report) - Investment analysts at Leerink Partnrs decreased their FY2024 earnings per share (EPS) estimates for PureTech Health in a research report issued on Tuesday, November 19th. Leerink Partnrs analyst F. Khurshid now anticipates that the company will pNovember 21, 2024 | marketbeat.comPureTech Health Strengthens Leadership at Seaport TherapeuticsNovember 20, 2024 | markets.businessinsider.comPureTech Health plc (NASDAQ:PRTC) Short Interest Up 18.9% in OctoberPureTech Health plc (NASDAQ:PRTC - Get Free Report) was the recipient of a large increase in short interest in October. As of October 31st, there was short interest totalling 6,300 shares, an increase of 18.9% from the October 15th total of 5,300 shares. Based on an average daily volume of 5,200 shares, the short-interest ratio is presently 1.2 days.November 17, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Sees Strong Trading Volume - Here's What HappenedPureTech Health (NASDAQ:PRTC) Sees Strong Trading Volume - Should You Buy?November 11, 2024 | marketbeat.comPureTech Health plc (NASDAQ:PRTC) Short Interest UpdatePureTech Health plc (NASDAQ:PRTC - Get Free Report) was the target of a significant decrease in short interest in the month of October. As of October 15th, there was short interest totalling 5,300 shares, a decrease of 24.3% from the September 30th total of 7,000 shares. Based on an average daily volume of 4,800 shares, the short-interest ratio is presently 1.1 days.October 27, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down - Time to Sell?PureTech Health (NASDAQ:PRTC) Shares Gap Down - Here's What HappenedOctober 22, 2024 | marketbeat.comPureTech Founded Entity Seaport Therapeutics Closes $225 Million Oversubscribed Series B Financing RoundOctober 21, 2024 | finance.yahoo.comPureTech Health plc (NASDAQ:PRTC) Short Interest Down 28.6% in SeptemberPureTech Health plc (NASDAQ:PRTC - Get Free Report) saw a large drop in short interest during the month of September. As of September 30th, there was short interest totalling 7,000 shares, a drop of 28.6% from the September 15th total of 9,800 shares. Based on an average daily volume of 4,400 shares, the short-interest ratio is currently 1.6 days.October 12, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up - Here's WhyPureTech Health (NASDAQ:PRTC) Shares Gap Up - Time to Buy?October 11, 2024 | marketbeat.comPureTech to Present at CHEST 2024 Annual MeetingOctober 1, 2024 | nz.finance.yahoo.comPureTech Health (PRTC) Gets a Buy from Leerink PartnersOctober 1, 2024 | markets.businessinsider.comSchizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb's Cobenfy As First New Class Of Treatment In More Than 3 DecadesSeptember 27, 2024 | benzinga.comPureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in AdultsSeptember 27, 2024 | finance.yahoo.comLeerink Partnrs Comments on PureTech Health plc's FY2024 Earnings (NASDAQ:PRTC)PureTech Health plc (NASDAQ:PRTC - Free Report) - Leerink Partnrs issued their FY2024 earnings estimates for PureTech Health in a research note issued on Monday, September 9th. Leerink Partnrs analyst F. Khurshid anticipates that the company will post earnings per share of ($4.27) for the year. LSeptember 11, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Trading Up 9%PureTech Health (NASDAQ:PRTC) Stock Price Up 9%September 9, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Now Covered by Leerink PartnersLeerink Partners began coverage on PureTech Health in a research note on Monday. They issued an "outperform" rating and a $45.00 price target for the company.September 9, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Sees Large Volume IncreasePureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading VolumeSeptember 5, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $23.00PureTech Health (NASDAQ:PRTC) Shares Gap Down to $23.00September 3, 2024 | marketbeat.comBirch Hill Investment Advisors LLC Buys Shares of 302,000 PureTech Health plc (NASDAQ:PRTC)Birch Hill Investment Advisors LLC bought a new stake in shares of PureTech Health plc (NASDAQ:PRTC - Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 302,000 shares of the company's stock, valuedAugust 31, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Stock Price Down 3.9%PureTech Health (NASDAQ:PRTC) Trading Down 3.9%August 29, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $25.00PureTech Health (NASDAQ:PRTC) Shares Gap Down to $25.00August 28, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Trading 8.7% Higher PureTech Health (NASDAQ:PRTC) Trading Up 8.7%August 27, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $22.45PureTech Health (NASDAQ:PRTC) Shares Gap Up to $22.45August 26, 2024 | marketbeat.comHere’s why I’d buy these FTSE 250 stocks near 52-week lowsAugust 23, 2024 | uk.finance.yahoo.comPureTech Appoints Michele Holcomb, PhD, to Board of DirectorsAugust 22, 2024 | stockhouse.comAre these 2 FTSE 250 shares now unmissable buys after crashing 48%?August 21, 2024 | msn.comPureTech Health (NASDAQ:PRTC) Shares Down 3.7% PureTech Health (NASDAQ:PRTC) Trading Down 3.7%August 15, 2024 | marketbeat.comPureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of CommercialJuly 23, 2024 | finance.yahoo.comPureTech Health (NASDAQ:PRTC) Stock Price Down 4.8%PureTech Health (NASDAQ:PRTC) Trading Down 4.8%July 16, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Shares Up 4.6%PureTech Health (NASDAQ:PRTC) Trading 4.6% HigherJuly 10, 2024 | marketbeat.comPureTech Health (NASDAQ:PRTC) Stock Price Down 6.3%PureTech Health (NASDAQ:PRTC) Stock Price Down 6.3%June 25, 2024 | marketbeat.comPureTech Announces Change of Board RoleJune 20, 2024 | businesswire.comPureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management TeamJune 18, 2024 | businesswire.comPureTech Health: Results of Annual General MeetingJune 13, 2024 | businesswire.comPureTech Health (NASDAQ:PRTC) Shares Gap Down to $32.98PureTech Health (NASDAQ:PRTC) Shares Gap Down to $32.98June 3, 2024 | marketbeat.comPureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health CompanyMay 29, 2024 | businesswire.comPureTech to Present at the Jefferies Global Healthcare ConferenceMay 23, 2024 | businesswire.comPureTech Health (NASDAQ:PRTC) Shares Gap Up to $28.68PureTech Health (NASDAQ:PRTC) Shares Gap Up to $28.68May 21, 2024 | marketbeat.comPureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile InfectionMay 21, 2024 | businesswire.comPureTech Health plc: PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareMay 20, 2024 | finanznachrichten.dePureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary ShareMay 20, 2024 | businesswire.com Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address AI breakthrough about to upend industry (Ad)Everyone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the market in late 2022. You might think it’s way too late to invest in AI. But here’s the thing. I urge you to watch it now. PRTC Media Mentions By Week PRTC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PRTC News Sentiment▼0.660.60▲Average Medical News Sentiment PRTC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PRTC Articles This Week▼51▲PRTC Articles Average Week Get PureTech Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PRTC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies APGE News IBRX News WVE News MIRM News AKRO News TARS News AMPH News IRON News CGON News HRMY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PRTC) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PureTech Health plc Please log in to your account or sign up in order to add this asset to your watchlist. Share PureTech Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
